Cancer Family
Neck Neoplasm
CI-CAN-00000283Explore in graph →
Non-malignant634 active trials11 approved drugs67 evidence items
- NCIt
- C3260
Loading cancer entity…
Cancer Family
CI-CAN-00000283Explore in graph →
Clinical trials
2,377 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03904225 | Tegio Consolidation Therapy for NPC Patients With High Risk of Metastasis | unknown | Phase 2 | 220 | Zhejiang Cancer HospitalOTHER | 1 | Jun 23, 2021 | clinicaltrials |
| NCT04916262 | Correlation Between TCM Syndrome Factors and TSH Changes of Thyroid Hormone Withdrawal Before Iodine Therapy in Postoperative Patients With Thyroid Cancer | unknown | — | 160 | Qianfoshan HospitalOTHER | 0 | Jun 16, 2021 | clinicaltrials |
| NCT04905030 | Education, Immigration and HPV Vaccination: an Informational Randomized Trial | unknown | N/A | 2,500 | Karolinska InstitutetOTHER | 1 | Jun 11, 2021 | clinicaltrials |
| NCT04917770 | The Efficacy and Safety of Sintilimab in Combination With Multimodal Radiotherapy in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma | unknown | Phase 2 | 28 | West China HospitalOTHER | 0 | Jun 8, 2021 | clinicaltrials |
| NCT04904159 | Scoring System for Thyroid Gland Pathologies | unknown | — | 300 | Dr. Lutfi Kirdar Kartal Training and Research HospitalOTHER_GOV | 1 | Jun 1, 2021 | clinicaltrials |
| NCT04051099 | Bilateral Superficial Cervical Plexus Block in Thyroid/Parathyroid Surgery | unknown | N/A | 52 | Mahidol UniversityOTHER | 1 | May 24, 2021 | clinicaltrials |
| NCT04883294 | Validation of the Diagnostic Accuracy of the Electronic Nose in the Detection of Thyroid Cancer | unknown | — | 1,500 | Maastricht University Medical CenterOTHER | 0 | May 12, 2021 | clinicaltrials |
| NCT04867330 | Toripalimab Based Induction Chemotherapy Followed by De-escalation Protocols in HPV-related OPSCC | unknown | N/A | 46 | Fudan UniversityOTHER | 1 | Apr 30, 2021 | clinicaltrials |
| NCT04745741 | Evaluating the Rationality of the International Guideline About Selective Coverage of Level Ib in CTV With NPC | unknown | — | 200 | Fujian Cancer HospitalOTHER_GOV | 1 | Apr 29, 2021 | clinicaltrials |
| NCT04309136 | Anlotinib Neoadjuvant Treatment in Locally Advanced Thyroid Cancer | unknown | Phase 2 | 13 | Fudan UniversityOTHER | 1 | Apr 1, 2021 | clinicaltrials |
| NCT04810936 | Early Nutritional Intervention in NPC Patients Undergoing Concurrent Chemoradiotherapy | unknown | N/A | 272 | Guangdong Provincial People's HospitalOTHER | 1 | Mar 23, 2021 | clinicaltrials |
| NCT03377829 | A Multicenter Trial of PLA vs. Surgery for Treating PTMC | unknown | N/A | 200 | WeiWei ZhanOTHER | 2 | Mar 19, 2021 | clinicaltrials |
| NCT04554680 | Clinical Trial in RAI-Refractory Thyroid Carcinoma Evaluating BRAF & MEK Blockade for Re-differentiation Therapy | unknown | Phase 2 | 5 | National University Hospital, SingaporeOTHER | 1 | Mar 5, 2021 | clinicaltrials |
| NCT04769076 | The Paclitaxel (Albumin-bound) Combined With Cisplatin, PD-1 Inhibitors and IMRT in the Treatment of Nasopharyngeal Carcinoma | unknown | Phase 2 | 40 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolOTHER | 0 | Feb 25, 2021 | clinicaltrials |
| NCT04766359 | Paclitaxel (Albumin-bound) Combined With Radiotherapy for the Treatment of Early Stage Nasopharyngeal Carcinoma | unknown | Phase 3 | 364 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolOTHER | 0 | Feb 23, 2021 | clinicaltrials |
| NCT04764149 | Platinum Plus Low-dose Long-term Continuous Intravenous Infused 5-Fluorouracil in Recurrent Nasopharyngeal Carcinoma | unknown | — | 801 | Sun Yat-sen UniversityOTHER | 1 | Feb 21, 2021 | clinicaltrials |
| NCT04760171 | Amyloid Proteins From Medullary Thyroid Cancer and Laryngeal Amyloidosis | unknown | — | 10 | The Leeds Teaching Hospitals NHS TrustOTHER | 0 | Feb 18, 2021 | clinicaltrials |
| NCT02636231 | Endostar for Locally Recurrent Nasopharyngeal Carcinoma | unknown | Phase 2 | 96 | Sun Yat-sen UniversityOTHER | 1 | Feb 3, 2021 | clinicaltrials |
| NCT01817023 | The Role of Concurrent Chemotherapy for Lower Risk Locally Advanced Nasopharyngeal Carcinoma(NPC) in the Era of IMRT | unknown | Phase 3 | 590 | Chinese Academy of Medical SciencesOTHER | 1 | Jan 29, 2021 | clinicaltrials |
| NCT02156362 | Determination of Pronostics Factors for Advanced Thyroid Carcinoma (pT3 pT4 or M1 at Diagnosis) | unknown | N/A | 643 | Hospices Civils de LyonOTHER | 1 | Jan 29, 2021 | clinicaltrials |
| NCT03558035 | New Strategy of Improving Treatment Outcome and Larynx-preservation Rate in Locally Advanced Hypopharyngeal Carcinoma | unknown | Phase 2 | 96 | Chinese Academy of Medical SciencesOTHER | 1 | Jan 29, 2021 | clinicaltrials |
| NCT03874572 | Allogeneic Mesenchymal Stem Cells for Radiation-induced Hyposalivation and Xerostomia/Dry Mouth(MESRIX-SAFETY) | unknown | Phase 1 | 10 | Rigshospitalet, DenmarkOTHER | 1 | Jan 29, 2021 | clinicaltrials |
| NCT03908372 | Optimized Treatment Strategies for Early and Medium Stage Nasopharyngeal Carcinoma | unknown | Phase 2 / Phase 3 | 120 | Chinese Academy of Medical SciencesOTHER | 1 | Jan 29, 2021 | clinicaltrials |
| NCT03915132 | Nimotuzumab Combined With VMAT in Elderly Patients With Nasopharyngeal Carcinoma | unknown | Phase 2 | 47 | Chinese Academy of Medical SciencesOTHER | 1 | Jan 29, 2021 | clinicaltrials |
| NCT04724590 | OPHTHALMOLOGIC EVALUATION OF RADIATION-RELATED OPTIC NEUROPATHY FOLLOWING IMAGE GUIDED INTENSITY-MODULATED RADIATION THERAPY (IMRT) FOR NASOPHARYNGEAL CARCİNOMA(ORONIN) | unknown | N/A | 15 | Istanbul University - CerrahpasaOTHER | 1 | Jan 26, 2021 | clinicaltrials |
| NCT04440618 | Prevalence of Obstructive Sleep Apnea Hypopnea Syndrome (OSAHS) Following Squamous Cell Carcinomas of the Oropharynx Treatment by Combined Chemoradiotherapy(COROSAS) | unknown | — | 30 | Poitiers University HospitalOTHER | 1 | Jan 14, 2021 | clinicaltrials |
| NCT01774279 | interNational Anaplastic Thyroid Cancer Tissue Bank and Database (iNATT)(iNATT) | unknown | — | 350 | Velindre NHS TrustOTHER_GOV | 2 | Jan 5, 2021 | clinicaltrials |
| NCT00662662 | Sexual Behavior in Head and Neck Cancer Patients | unknown | — | 1,500 | M.D. Anderson Cancer CenterOTHER | 1 | Dec 30, 2020 | clinicaltrials |
| NCT04664413 | Percentage of BRAFV600E Alleles and Outcome in Thyroid Carcinoma(ABOUT) | unknown | — | 300 | University of SalernoOTHER | 1 | Dec 14, 2020 | clinicaltrials |
| NCT03896958 | The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)(PIONEER) | unknown | — | 1,000 | SpeciCareINDUSTRY | 1 | Dec 4, 2020 | clinicaltrials |
| NCT03845647 | Significance of Contralateral Central Lymph Node Dissection in Unilateral cN0 Differentiated Thyroid Carcinoma. | unknown | N/A | 50 | Fifth Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 1 | Nov 24, 2020 | clinicaltrials |
| NCT04627961 | A Trial of LONSURF in Recurrent/Metastatic Nasopharyngeal Carcinoma | unknown | Phase 2 | 33 | National University Hospital, SingaporeOTHER | 1 | Nov 13, 2020 | clinicaltrials |
| NCT04624308 | Toripalimab Plus TPF Chemotherapy and Radiotherapy for LA-HPSCC | unknown | Phase 2 | 81 | Sun YanOTHER | 1 | Nov 10, 2020 | clinicaltrials |
| NCT03643055 | 18F-Fluorocholine PET/CT in Medullary Thyroid Cancer | unknown | — | 80 | University Medical Centre LjubljanaOTHER | 1 | Nov 4, 2020 | clinicaltrials |
| NCT04612894 | Camrelizumab and Apatinib for Neoadjuvant Therapy in Thyroid Cancer | unknown | Phase 2 | 31 | Fudan UniversityOTHER | 1 | Nov 3, 2020 | clinicaltrials |
| NCT04278638 | IORT in Local Advanced Laryngocarcinoma(ILAL) | unknown | N/A | 120 | Tianjin First Central HospitalOTHER | 1 | Oct 23, 2020 | clinicaltrials |
| NCT03025854 | Prospective Study for Prognostic Biomarkers of Nasopharyngeal Carcinoma | unknown | — | 600 | Sun Yat-sen UniversityOTHER | 1 | Oct 12, 2020 | clinicaltrials |
| NCT04574817 | Study of HX008 for the Treatment of Anaplastic Thyroid Cancer (ATC) | unknown | Phase 2 | 66 | Taizhou Hanzhong biomedical co. LTDINDUSTRY | 1 | Oct 5, 2020 | clinicaltrials |
| NCT03048305 | Prospective Study for Molecular Biomarkers of Normal Nasopharyngeal Tissue | unknown | — | 200 | Sun Yat-sen UniversityOTHER | 1 | Sep 25, 2020 | clinicaltrials |
| NCT04560426 | Protective Effect of Intraoperative Parathyroid Gland Auxiliary Recognition System in Thyroid Malignant Tumor Operation | unknown | N/A | 200 | Fudan UniversityOTHER | 1 | Sep 23, 2020 | clinicaltrials |
| NCT03129412 | Oligo-metastases NPC Patients Received Radiation for Primary Tumors and Treatments for Metastatic Lesions | unknown | Phase 2 | 64 | Zhejiang Cancer HospitalOTHER | 1 | Sep 17, 2020 | clinicaltrials |
| NCT04553510 | Treatment of Bevacizumab Followed by Steroid in RN | unknown | Phase 2 | 86 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Sep 17, 2020 | clinicaltrials |
| NCT04547088 | Camrelizumab Combined With Apatinib in Patients With First-line Platinum-resistant Recurrent/Metastatic Nasopharyngeal Carcinoma | unknown | Phase 2 | 27 | Sun Yat-sen UniversityOTHER | 1 | Sep 14, 2020 | clinicaltrials |
| NCT04548271 | Camrelizumab Combined With Apatinib in Patients With PD-1 Antagonists Resistant Recurrent/Metastatic Nasopharyngeal Carcinoma | unknown | Phase 2 | 25 | Sun Yat-sen UniversityOTHER | 1 | Sep 14, 2020 | clinicaltrials |
| NCT04538547 | Randomized Trial to Evaluate Accelerated Radiotherapy in Locally Advanced Carcinoma of Nasopharynx(EARN) | unknown | N/A | 120 | Post Graduate Institute of Medical Education and Research, ChandigarhOTHER | 1 | Sep 4, 2020 | clinicaltrials |
| NCT04534855 | A Phase II Clinical Study of Treprilimab in the Treatment of Recurrent Nasopharyngeal Carcinoma After Re-irradiation | unknown | Phase 2 | 40 | Sun Yat-sen UniversityOTHER | 0 | Sep 1, 2020 | clinicaltrials |
| NCT04524884 | Toripalimab Combined With Surufatinib for Locally Advanced Thyroid Cancer: a Phase II Study | unknown | Phase 2 | 10 | Fudan UniversityOTHER | 1 | Aug 24, 2020 | clinicaltrials |
| NCT02476669 | Serial Plasma EBV DNA for Nasopharyngeal Carcinoma | unknown | — | 900 | The University of Hong KongOTHER | 1 | Aug 14, 2020 | clinicaltrials |
| NCT03648697 | EBV-TCR-T(YT-E001)for Patients With EBV-positive Recurrent or Metastatic NPC | unknown | Phase 2 | 20 | Fujian Cancer HospitalOTHER_GOV | 1 | Aug 11, 2020 | clinicaltrials |
| NCT03720340 | Interleukin-11 Can Prevent and Treat of Radioactive Oral Mucitis | unknown | Phase 3 | 300 | Zhejiang Cancer HospitalOTHER | 1 | Aug 11, 2020 | clinicaltrials |
Data updated 23 days agoSource updated Jun 23, 2021source: clinicaltrials